Dsp Clinical Research is categorized under Medical Research in Parsippany, NJ and active since 2004.
Dsp Clinical Research was established in 2004, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 5417115 by the NAICS.
If you are seeking more information, feel free to contact Darlene Panzitta, President at the company’s single location by writing to 300 Interpace Parkway # 130, Parsippany, New Jersey NJ 07054 or by phoning (973) 265-1060. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Dsp Clinical Research |
| Contact Person: | Darlene Panzitta, President |
| Address: | 300 Interpace Parkway # 130, Parsippany, New Jersey 07054 |
| Phone Number: | (973) 265-1060 |
| Website Address: | dspclinical.com |
| Annual Revenue (USD): | $5.000.000 to $9.999.999 |
| Founded: | 2004 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Medical Research |
| SIC Code: | 8733 |
| NAICS Code: | 5417115 |
| Share This Business: |
Dsp Clinical Research was started in 2004 to provide professional Medical Research under the SIC code 8733 and NAICS code 5417115. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.
Feel free to contact Darlene Panzitta, President for inquiries that concern Dsp Clinical Research by calling the company number (973) 265-1060, as your correspondence is most welcome. Additionally, the physical location of the single location of Dsp Clinical Research can be found at the coordinates 40.87141,-74.450179 as well as the street address 300 Interpace Parkway # 130 in Parsippany, New Jersey 07054.
For its online presence, you may visit Dsp Clinical Research’s website at dspclinical.com and engage with its social media outlets through on Twitter and on Facebook.